Albinger, N

Comparison of CD28- and 4-1BB-based CLEC12A-CAR-natural killer cells against acute myleoid leukemia

Alejo, O

Identifying Gene Targets for Drug repurposing to prevent Cancer in children with a premalignant state

Antić, Ž

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

Armstrong, S A

Exploring the novel function of mutant NPM1 on chromatin

Aschero, R

An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Ashtiani, M

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Menin Inhibition In Hox/Meis1 Dysregulated Amls

Bader, P

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

Banito, A

Radiosensitivity in pediatric solid tumors

Bardini, M

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

Barneh, F

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Barrett, A

Expression of retinoic acid receptor gamma is modulated by miR-30a

Bartels, A

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Barthel, L

Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell

Bataller, A

Single cell multiomic analysis of clonal and transcriptional programs of CD19 CAR T cells in the immunotherapy response

Baumhoer, D

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

SarcDBase: a tool for detection of genetic alterations in sarcoma

Belderbos, M E

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Benz, T

Optimizing CRISPR/Cas9 technologies to develop disease model systems

Bergmann, A K

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Bethke, M

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Bhayadia, R

Targeting the non-coding ands stem cell signature in childhood acute myeloid leukemia

Targeting the fetal transcriptional landscape of pediatric AML

Identifying Gene Targets for Drug repurposing to prevent Cancer in children with a premalignant state

A screening of donated chemical probes to identify novel therapeutic options for childhood AML

Restoration of miRNA-193b-3p function is a potent therapeutic option in acute myeloid leukemias

Comparison of CD28- and 4-1BB-based CLEC12A-CAR-natural killer cells against acute myleoid leukemia

Decoding Epigenetic Landscape in Pediatric Leukemia through Multi-Omics Integration

Bidgoli, M

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Blair, H J

Single cell RNAseq uncovering the role of RUNX1/ETO in the leukemic niche signaling

Bohler, S

Association and interactions of the RIO kinases in the context of Diamond-Blackfan anemia

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Bönig, H B

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

Born, A

Comparison of CD28- and 4-1BB-based CLEC12A-CAR-natural killer cells against acute myleoid leukemia

Braun, C

From bench to bedside – Establishing PRMT5 inhibitors in the treatment of Glioblastoma multiforme

Braun, C J

Examination of RNA exosome mediated RNA decay as context-dependent cellular vulnerability

Brors, B

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Brosjö, O

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Brown, G

Expression of retinoic acid receptor gamma is modulated by miR-30a

Brummer, T

Association and interactions of the RIO kinases in the context of Diamond-Blackfan anemia

Bueno, C

A novel fratricide-resistant CAR-T cell immunotherapy for T-ALL

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Single cell multiomic analysis of clonal and transcriptional programs of CD19 CAR T cells in the immunotherapy response

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Burkhardt, B

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Cairo, S

Understanding Nfe2l2/Keap1-Mediated Drug Resistance In Hepatoblastoma

Camiolo, G

CSF1R as a marker of lineage plasticity in MLL-AF9 infant leukaemia

Caracuel-Peramos, R

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

Carbonell, Adames A

Transcription vulnerabilities profiling through combinatorial CRISPR screens for personalized pediatric cancer therapy

Carcaboso, A M

An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Cario, G

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Cases i Palau, S

Deciphering the role of KANSL1 mutations in the development of Myeloid Leukemia in children with Down Syndrome (ML-DS)

Castilla, C

An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Cetin, R

Targeting the non-coding ands stem cell signature in childhood acute myeloid leukemia

Chen, C W

Exploring the novel function of mutant NPM1 on chromatin

Chetty, V K

Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell

Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow

AML-derived small EVs containing YBX1 influences mesenchymal stromal cells differentiation in the bone marrow niche

Chudakov, D

Application of VDJ recombination events probability for γδ T-cells in MRD monitoring

Cinar, B

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Cinatl, J

NK cell immunotherapy against chemotherapy-resistant rhabdomyosarcoma

Collazo, O

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

Cornmark, L

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Cross, J

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Crump, N

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

de Álava, E

An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

de Barrios, O

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

Debatin, K M

Early subclinical CNS manifestation in B-cell acute lymphoblastic leukemia modelled in vivo

Effective targeting of Wnt Signaling in B Cell Precursor Acute Lymphoblastic Leukemia

Characterizing the role of BCL-2 family members as targets for anti-cancer therapy in T-ALL

Debatin, KM

Synergistic anti-leukemia activity of the dual mTOR/PI3K inhibitor NVP-BEZ235 with the BCL-2 inhibitor venetoclax

de Groot-Kruseman, H A

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Derevyanko, P K

Single cell RNAseq uncovering the role of RUNX1/ETO in the leukemic niche signaling

Díaz, V M

A novel fratricide-resistant CAR-T cell immunotherapy for T-ALL

di Bernardo, D

Understanding Nfe2l2/Keap1-Mediated Drug Resistance In Hepatoblastoma

Díez Alonso, L

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Difilippo, V

SarcDBase: a tool for detection of genetic alterations in sarcoma

DJC, Spierings

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Duguid, A

Leukaemia in the CNS niche regulates PI3K/Akt signalling via upregulation of miR-93 in MLL-AF4+ infant leukaemia

Dunnebach, E

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Eckert, C

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

The transcriptional landscape and the immune microenvironment of the testicular niche in pediatric ALL

Eder, T

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

ElHarouni, D

Radiosensitivity in pediatric solid tumors

Elliott, N E

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Enzenmüller, S

Synergistic anti-leukemia activity of the dual mTOR/PI3K inhibitor NVP-BEZ235 with the BCL-2 inhibitor venetoclax

Erlacher, M

Association and interactions of the RIO kinases in the context of Diamond-Blackfan anemia

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Identification of Functional Defects Leading to Bone Marrow Failure in GATA2 Deficiency

Identification of cell-extrinsic pro-survival factors in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Failli, M

Understanding Nfe2l2/Keap1-Mediated Drug Resistance In Hepatoblastoma

Falgàs, A

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Fedders, B

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

Fehlhaber, B

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Feldmeyer, L

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Fernández-Fuentes, N

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse

A novel fratricide-resistant CAR-T cell immunotherapy for T-ALL

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

Fernandez-Orth, J

Identification of Functional Defects Leading to Bone Marrow Failure in GATA2 Deficiency

Fernandez-Pernas, P

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

Fiocco, M

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Fischer, T T

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Foijer, F

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Fortner, C

Characterizing the role of BCL-2 family members as targets for anti-cancer therapy in T-ALL

Fritzberg, A

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Gade, C

Radiosensitivity in pediatric solid tumors

Gahleitner, L

From bench to bedside – Establishing PRMT5 inhibitors in the treatment of Glioblastoma multiforme

Ghanam, J

Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell

Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow

AML-derived small EVs containing YBX1 influences mesenchymal stromal cells differentiation in the bone marrow niche

Gierschek, F

Comparison of CD28- and 4-1BB-based CLEC12A-CAR-natural killer cells against acute myleoid leukemia

Giraud, G

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Goncalves-Dias, J M

Identification of novel fusion transcripts in Acute Myeloid Leukemia

Goncalves-Dias, JM

Decoding Epigenetic Landscape in Pediatric Leukemia through Multi-Omics Integration

Grebien, F

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

Grigoryeva, T

Application of VDJ recombination events probability for γδ T-cells in MRD monitoring

Guerrero-Murillo, M

Single cell multiomic analysis of clonal and transcriptional programs of CD19 CAR T cells in the immunotherapy response

Gusi-Vives, M

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

Haarer, E L

Exploring the novel function of mutant NPM1 on chromatin

Habermann, J

Comparison of armored NK cells equipped with soluble and membrane-bound IL-15 variants for improved functionality

Haglund de Flon, F

SarcDBase: a tool for detection of genetic alterations in sarcoma

Halsey, C

Leukaemia in the CNS niche regulates PI3K/Akt signalling via upregulation of miR-93 in MLL-AF4+ infant leukaemia

Hanewald, T

Impact of posttranscriptional regulations of MLL-AF4 and its target Genes in pro B-ALL

Harman, J R

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Hartig, L

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Hartmann, J

Comparison of armored NK cells equipped with soluble and membrane-bound IL-15 variants for improved functionality

Hartmann, M

RAS pathway mutations drive oncofetal reprogramming in hematopoietic stem cells

Hatton, C

Exploring the novel function of mutant NPM1 on chromatin

Hauck, J K

Comparison of armored NK cells equipped with soluble and membrane-bound IL-15 variants for improved functionality

Heckl, D

Targeting the non-coding ands stem cell signature in childhood acute myeloid leukemia

Targeting the fetal transcriptional landscape of pediatric AML

Identifying Gene Targets for Drug repurposing to prevent Cancer in children with a premalignant state

Restoration of miRNA-193b-3p function is a potent therapeutic option in acute myeloid leukemias

Decoding Epigenetic Landscape in Pediatric Leukemia through Multi-Omics Integration

Deciphering the role of KANSL1 mutations in the development of Myeloid Leukemia in children with Down Syndrome (ML-DS)

Heidenreich, O

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Menin Inhibition In Hox/Meis1 Dysregulated Amls

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Single cell RNAseq uncovering the role of RUNX1/ETO in the leukemic niche signaling

Heim, C

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Hidajat, J S

Targeting the fetal transcriptional landscape of pediatric AML

Hinze, L

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Hofmann, W

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Hollfoth, V

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Hotfilder, M

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Howell, L

Expression of retinoic acid receptor gamma is modulated by miR-30a

Humer, T

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

Ibrahim, NK

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Imle, R

Radiosensitivity in pediatric solid tumors

Issa, H

Restoration of miRNA-193b-3p function is a potent therapeutic option in acute myeloid leukemias

Deciphering the role of KANSL1 mutations in the development of Myeloid Leukemia in children with Down Syndrome (ML-DS)

Jackson, T R

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Jakobczyk, H

The role of the DACH family of nuclear proteins in MLL-AF4-associated infant leukaemia

Jalili, L

NK cell immunotherapy against chemotherapy-resistant rhabdomyosarcoma

Jeremias, I

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse

Jonson, T

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Kappler, R

Understanding Nfe2l2/Keap1-Mediated Drug Resistance In Hepatoblastoma

Kapsali, E

Methyltransferase-dependent and -independent functions of EZH2 in H3K27M-mutant diffuse intrinsic pontine gliomas

Kaspers, G

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Kaulich, M

Targeting the non-coding ands stem cell signature in childhood acute myeloid leukemia

Kern, U

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Khalida Ibrahim, N

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Klusmann, J H

Identification and functional characterization of CTCF-bound noncoding RNA loci in acute myeloid leukemia.

Targeting the non-coding ands stem cell signature in childhood acute myeloid leukemia

Identification of novel fusion transcripts in Acute Myeloid Leukemia

Targeting the fetal transcriptional landscape of pediatric AML

Identifying Gene Targets for Drug repurposing to prevent Cancer in children with a premalignant state

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

A screening of donated chemical probes to identify novel therapeutic options for childhood AML

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Restoration of miRNA-193b-3p function is a potent therapeutic option in acute myeloid leukemias

Comparison of CD28- and 4-1BB-based CLEC12A-CAR-natural killer cells against acute myleoid leukemia

Decoding Epigenetic Landscape in Pediatric Leukemia through Multi-Omics Integration

Deciphering the role of KANSL1 mutations in the development of Myeloid Leukemia in children with Down Syndrome (ML-DS)

Knapp, S

A screening of donated chemical probes to identify novel therapeutic options for childhood AML

Koedijk, J

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Koedijk, J B

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Koehler, R

Early subclinical CNS manifestation in B-cell acute lymphoblastic leukemia modelled in vivo

Koleci, N

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Identification of cell-extrinsic pro-survival factors in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Komkov, A

Application of VDJ recombination events probability for γδ T-cells in MRD monitoring

Kovacsovics, A

The transcriptional landscape and the immune microenvironment of the testicular niche in pediatric ALL

Kramm, C

Inhibition of autophagy as therapeutic approach for pediatric diffuse intrinsic pontine glioma

Identification of the genetic mechanisms linked to the occurrence of H3.3K27M-mutation in pediatric DIPG

Methyltransferase-dependent and -independent functions of EZH2 in H3K27M-mutant diffuse intrinsic pontine gliomas

Krippner-Heidenreich, A

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Menin Inhibition In Hox/Meis1 Dysregulated Amls

Single cell RNAseq uncovering the role of RUNX1/ETO in the leukemic niche signaling

Kubiak, K

Identification of the genetic mechanisms linked to the occurrence of H3.3K27M-mutation in pediatric DIPG

Lanvers-Kaminsky, C

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Larghero, P

Optimizing CRISPR/Cas9 technologies to develop disease model systems

Laszig, S

A screening of donated chemical probes to identify novel therapeutic options for childhood AML

Lebedev, Y

Application of VDJ recombination events probability for γδ T-cells in MRD monitoring

Lichá, K

Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell

Ling, R E

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Lipka, D B

RAS pathway mutations drive oncofetal reprogramming in hematopoietic stem cells

Liu, S

Effective targeting of Wnt Signaling in B Cell Precursor Acute Lymphoblastic Leukemia

Lopez-Millan, B

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

Loxha, L

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Lühmann, J L

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Maaß, K K

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Magnusson, L

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Malouf, C

Leukaemia in the CNS niche regulates PI3K/Akt signalling via upregulation of miR-93 in MLL-AF4+ infant leukaemia

Mamedov, I

Application of VDJ recombination events probability for γδ T-cells in MRD monitoring

Manhart, G

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

Marschalek, R

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

Impact of posttranscriptional regulations of MLL-AF4 and its target Genes in pro B-ALL

Optimizing CRISPR/Cas9 technologies to develop disease model systems

Martínez-Moreno, A

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse

A novel fratricide-resistant CAR-T cell immunotherapy for T-ALL

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Meier, K

Identifying Gene Targets for Drug repurposing to prevent Cancer in children with a premalignant state

Meisel, R

Identification of Functional Defects Leading to Bone Marrow Failure in GATA2 Deficiency

Meister, M T

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Meler, A

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

Mellgren, K

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Menéndez, P

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse

A novel fratricide-resistant CAR-T cell immunotherapy for T-ALL

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Single cell multiomic analysis of clonal and transcriptional programs of CD19 CAR T cells in the immunotherapy response

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Mereu, E

Single cell multiomic analysis of clonal and transcriptional programs of CD19 CAR T cells in the immunotherapy response

Merker, M

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

Meulendijks, T

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Meyer, L H

Early subclinical CNS manifestation in B-cell acute lymphoblastic leukemia modelled in vivo

Synergistic anti-leukemia activity of the dual mTOR/PI3K inhibitor NVP-BEZ235 with the BCL-2 inhibitor venetoclax

Effective targeting of Wnt Signaling in B Cell Precursor Acute Lymphoblastic Leukemia

Characterizing the role of BCL-2 family members as targets for anti-cancer therapy in T-ALL

Michael, J

Comparison of armored NK cells equipped with soluble and membrane-bound IL-15 variants for improved functionality

Michaelis, M

NK cell immunotherapy against chemotherapy-resistant rhabdomyosarcoma

Michgehl, U

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Milne, T A

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Mohnani, R

Menin Inhibition In Hox/Meis1 Dysregulated Amls

Mora, T

Application of VDJ recombination events probability for γδ T-cells in MRD monitoring

Möricke, A

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Moser, L M

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Muench, V

Early subclinical CNS manifestation in B-cell acute lymphoblastic leukemia modelled in vivo

Müller, S

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Narayanared dy, CG

The transcriptional landscape and the immune microenvironment of the testicular niche in pediatric ALL

Nathrath, M

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

SarcDBase: a tool for detection of genetic alterations in sarcoma

Nelson, R N

Single cell RNAseq uncovering the role of RUNX1/ETO in the leukemic niche signaling

Niedermayer, A

Synergistic anti-leukemia activity of the dual mTOR/PI3K inhibitor NVP-BEZ235 with the BCL-2 inhibitor venetoclax

Characterizing the role of BCL-2 family members as targets for anti-cancer therapy in T-ALL

Niemeyer, C M

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Niemeyer, CM

Association and interactions of the RIO kinases in the context of Diamond-Blackfan anemia

Nierkens, S

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Niessen, J

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Nilsson, J

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Nord, K H

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

SarcDBase: a tool for detection of genetic alterations in sarcoma

Oehme, I

Radiosensitivity in pediatric solid tumors

Orth, J F

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Ottersbach, K

The role of the DACH family of nuclear proteins in MLL-AF4-associated infant leukaemia

Leukaemia in the CNS niche regulates PI3K/Akt signalling via upregulation of miR-93 in MLL-AF4+ infant leukaemia

CSF1R as a marker of lineage plasticity in MLL-AF9 infant leukaemia

Pajtler, K W

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Radiosensitivity in pediatric solid tumors

Panisello, C

An innovative tailored CAR T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Parra, M

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

Perzolli, A

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Pesic, M

The transcriptional landscape and the immune microenvironment of the testicular niche in pediatric ALL

Petrie, K

Expression of retinoic acid receptor gamma is modulated by miR-30a

Pfau, M

The transcriptional landscape and the immune microenvironment of the testicular niche in pediatric ALL

Pfister, S M

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Pierre-Emmanuel Gleizes, P-E

Association and interactions of the RIO kinases in the context of Diamond-Blackfan anemia

Puranachot, P

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Puzik, A

Association and interactions of the RIO kinases in the context of Diamond-Blackfan anemia

Rajak, J

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Identification of cell-extrinsic pro-survival factors in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Randau, G

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Rasche, V

Early subclinical CNS manifestation in B-cell acute lymphoblastic leukemia modelled in vivo

Rasouli, M

Menin Inhibition In Hox/Meis1 Dysregulated Amls

Rassner, M G

Examination of RNA exosome mediated RNA decay as context-dependent cellular vulnerability

Reetz, L

Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell

Reindl, L M

NK cell immunotherapy against chemotherapy-resistant rhabdomyosarcoma

Reinhardt, D

Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell

Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow

AML-derived small EVs containing YBX1 influences mesenchymal stromal cells differentiation in the bone marrow niche

Rettinger, E

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Rill-Hinarejos, A

Single cell multiomic analysis of clonal and transcriptional programs of CD19 CAR T cells in the immunotherapy response

Robles-Valero, J

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

Rolfing, M

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Romecin, P A

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Rotari, A

Understanding Nfe2l2/Keap1-Mediated Drug Resistance In Hepatoblastoma

Rothweiler, F

NK cell immunotherapy against chemotherapy-resistant rhabdomyosarcoma

Roy, A

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Rubio-Gayarre, A

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

Saba, K H

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

SarcDBase: a tool for detection of genetic alterations in sarcoma

Salzmann-Manrique, E

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Sánchez-Martínez, D

A novel fratricide-resistant CAR-T cell immunotherapy for T-ALL

Sander, S L

Inhibition of autophagy as therapeutic approach for pediatric diffuse intrinsic pontine glioma

Sbirkov, Y

Expression of retinoic acid receptor gamma is modulated by miR-30a

Schlegelberger, B

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Schmell, A L

Targeting the fetal transcriptional landscape of pediatric AML

Schmell, AL

Identifying Gene Targets for Drug repurposing to prevent Cancer in children with a premalignant state

Schmid, J P

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse

Schmöllerl, J

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

Schönung, M

RAS pathway mutations drive oncofetal reprogramming in hematopoietic stem cells

Schrappe, M

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Schreek, S

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Schröder, C F

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

Schüler, L

Targeting the non-coding ands stem cell signature in childhood acute myeloid leukemia

Schuschel, K

Identification of novel fusion transcripts in Acute Myeloid Leukemia

Seyfried, F

Synergistic anti-leukemia activity of the dual mTOR/PI3K inhibitor NVP-BEZ235 with the BCL-2 inhibitor venetoclax

Characterizing the role of BCL-2 family members as targets for anti-cancer therapy in T-ALL

Shi, J-Y

Expression of retinoic acid receptor gamma is modulated by miR-30a

Siemund, A

Impact of posttranscriptional regulations of MLL-AF4 and its target Genes in pro B-ALL

Simon, N

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Smirnova, A

Application of VDJ recombination events probability for γδ T-cells in MRD monitoring

Smith, A L

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Staaf, J

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Stam, R W

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

A novel combinatorial therapy improves the outcome of t(4;11) infant pro-B-ALL through the precise induction of HDAC7 biomarker

Stanulla, M

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Stasche, A S

Wnt/STOP activation drives temporally dynamic ribosomal biogenesis in drug resistant leukemia cells

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Steinemann, D

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Styring, E

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Sumathi, V P

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

Sun, Q

Effective targeting of Wnt Signaling in B Cell Precursor Acute Lymphoblastic Leukemia

Suo, Y

Identification of Functional Defects Leading to Bone Marrow Failure in GATA2 Deficiency

Swart, L E

Restoration of miRNA-193b-3p function is a potent therapeutic option in acute myeloid leukemias

Single cell RNAseq uncovering the role of RUNX1/ETO in the leukemic niche signaling

Takeda, R

Exploring the novel function of mutant NPM1 on chromatin

Tang, M

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

Tann, A

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Terlecki-Zaniewicz, S

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

te Vrugt, M

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Thakur, B K

Medulloblastoma EVs influence TGF-beta/SMAD1 signaling in mesenchymal stem cell

Extracellular vesicles transfer chromatin-like structures that induce non-mutational dysfunction of p53 in bone marrow

AML-derived small EVs containing YBX1 influences mesenchymal stromal cells differentiation in the bone marrow niche

Tirado, N

A novel fratricide-resistant CAR-T cell immunotherapy for T-ALL

Tittmann, K

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Tölle, I

Rituximab clearance in pediatric patients with mature aggressive B-cell Non-Hodgkin Lymphoma

Functional Characterization of potential diagnostic targets in Burkitt-NHL

Tomazou, E

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

Trincado, J L

Single cell multiomic analysis of clonal and transcriptional programs of CD19 CAR T cells in the immunotherapy response

Tröster, S

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

Uckelmann, H J

Exploring the novel function of mutant NPM1 on chromatin

Ullrich, E

Comparison of armored NK cells equipped with soluble and membrane-bound IL-15 variants for improved functionality

NK cell immunotherapy against chemotherapy-resistant rhabdomyosarcoma

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

Comparison of CD28- and 4-1BB-based CLEC12A-CAR-natural killer cells against acute myleoid leukemia

van den Bos, H

TP53 separation-of-function mutations through promoter swapping in osteosarcoma

van der Werf, I

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

van der Wilt, C N

Single cell RNAseq uncovering the role of RUNX1/ETO in the leukemic niche signaling

van Wijk, SJ L

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Velasco-Hernández, T

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse

Vermeulen, M A

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Vermunt, M W

Identification of novel fusion transcripts in Acute Myeloid Leukemia

Vermunt, MW

Identification and functional characterization of CTCF-bound noncoding RNA loci in acute myeloid leukemia.

Vinyoles, M

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse

A novel fratricide-resistant CAR-T cell immunotherapy for T-ALL

NG2 and VLA-4 are involved in the invasion and migration of MLLr B-cell Acute Lymphoblastic Leukemia

Vogler, M

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

von Pappenheim, F R

Exopolyphosphatase Activity of PRUNE Regulates Adaptive Starvation Responses in Cancer Cells

Walczak, A

Application of VDJ recombination events probability for γδ T-cells in MRD monitoring

Wallander, K

SarcDBase: a tool for detection of genetic alterations in sarcoma

Wang, J

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Identification of cell-extrinsic pro-survival factors in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Wantzen, C

Identification of Functional Defects Leading to Bone Marrow Failure in GATA2 Deficiency

Wehner, N A

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Wehner, NA

Identification of cell-extrinsic pro-survival factors in JMML

Weinelt, N

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Weiss, J M

Identification of Functional Defects Leading to Bone Marrow Failure in GATA2 Deficiency

Wels, W S

NK cell immunotherapy against chemotherapy-resistant rhabdomyosarcoma

Choosing the right effector cell for ErbB2-CAR-engineered immunotherapy in rhabdomyosarcoma – CAR-T vs CAR-CIK

Enhancing TRAIL-mediated killing of ErbB2-CAR-NK-92 (NK-92/5.28.z) with bortezomib

Wendel, P

Comparison of armored NK cells equipped with soluble and membrane-bound IL-15 variants for improved functionality

Comparison of CD28- and 4-1BB-based CLEC12A-CAR-natural killer cells against acute myleoid leukemia

Wiese, M

Inhibition of autophagy as therapeutic approach for pediatric diffuse intrinsic pontine glioma

Identification of the genetic mechanisms linked to the occurrence of H3.3K27M-mutation in pediatric DIPG

Methyltransferase-dependent and -independent functions of EZH2 in H3K27M-mutant diffuse intrinsic pontine gliomas

Wijnen, N

CD19-Targeted immunotherapies for Treatment of Pediatric t(8;21) Leukemia

Winkler, R

Targeting the non-coding ands stem cell signature in childhood acute myeloid leukemia

Restoration of miRNA-193b-3p function is a potent therapeutic option in acute myeloid leukemias

Wu, Q Q

PROM1/CD133 expression identifies highly proliferative MLL-AF4+ blasts and correlates with a stem-like gene signature

Wulffen, H-D v

Association and interactions of the RIO kinases in the context of Diamond-Blackfan anemia

Xiao, H

Investigating and modulating leukemia initiating cells to reduce risk of post-transplant relapse in JMML

Identification of cell-extrinsic pro-survival factors in JMML

Inhibition of the ”don’t eat me signal” CD47 to prevent relapse in juvenile myelomonocytic leukemia

Ximeno-Parpal, P

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse

Yaspo, M L

The transcriptional landscape and the immune microenvironment of the testicular niche in pediatric ALL

Yigit, B

Identification of Functional Defects Leading to Bone Marrow Failure in GATA2 Deficiency

Zanetti, S R

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Zelent, A

Expression of retinoic acid receptor gamma is modulated by miR-30a

Zhang, S

Identification of Functional Defects Leading to Bone Marrow Failure in GATA2 Deficiency

Zimmermann, M

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

IKZF1plusplus? Investigating the genetic complexity of IKZF1 deleted B-cell acute lymphoblastic leukemia

Zinser, L

Comparison of armored NK cells equipped with soluble and membrane-bound IL-15 variants for improved functionality

Zuber, J

Oncogenic mechanisms of fusion proteins in pediatric acute myeloid leukemia

zur Stadt, U

Comprehensive molecular and clinical characterization of DUX4-rearranged B-acute lymphoblastic leukemia

Zwaan, C M

Menin Inhibition In Hox/Meis1 Dysregulated Amls

Spatial analysis reveals distinct immune phenotypes and tertiary lymphoid structure-like aggregates in pediatric AML

Álvarez Vallina, L

Blocking TIM3:Galectin-9 pathway enhances in vivo CAR19T cell function

Öber, A

Minimal invasive detection of circulating biomarkers in pediatric brain tumor patients using liquid biopsy

Łuczak, W

Acute Myeloid Leukemia initiating cells: identification of new therapeutic targets to avoid relapse